Patients who undergo open heart surgery, many of whom have medical comorbidity, are able to demonstrate substantial functional improvement on an inpatient rehabilitation program before hospital discharge.
A paucity of information exists concerning the mechanism and occurrence rate of stroke associated with cardiac transplantation. Furthermore, the rehabilitation of such patients has not been elaborated on. This report explores these issues and reviews the medical history and rehabilitation progress of four individuals who suffered a stroke before, or associated with, the transplantation process. Physiologic factors relevant to the rehabilitation of the post-heart transplantation stroke patient will also be discussed.
Venous thromboembolism is the most common and potentially lethal problem following elective or emergency hip surgery. Appropriate DVT prophylaxis is absolutely essential, as the incidence of both calf and proximal vein thrombosis is significant. Two to three percent of postoperative hip patients die secondary to pulmonary embolism.Prophylactic measures include a variety of pharmacological and non pharmacological tools. Early mobilization, leg exercises, and gradient compression stockings constitute a minimum protocol. Low-dose Coumadin or low molecular weight heparin should be employed as a pharmacological prophylaxis.If deep venous thrombosis is suspected, clinical judgment alone should not be a basis for treatment decisions. Venography or, if necessary, other modem diagnostic agents must be employed. If appropriate studies are positive, aggressive treatment with heparin followed by Coumadin is suggested.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.